Funded Health Care Startups in Copenhagen
Copenhagen’s most recently listed health care funding shows one clear size outlier: Orbis Medicines raised $93M on 2025-01-06 (Series A), which dwarfs ever…
Copenhagen’s most recently listed health care funding shows one clear size outlier: Orbis Medicines raised $93M on 2025-01-06 (Series A), which dwarfs every other disclosed amount in the table. Below that peak, the next-largest disclosed rounds are Dawn Health’s $13M (2025-05-05) and CathVision’s $9M (2023-07-18), while several other disclosed figures cluster far lower, including $730K (Cessatech, 2024-08-12) and $290K (CS MEDICA, 2024-05-28).
Timing and classification also cluster. The 12 rows span 2020-08-11 (Practio, $8M) through 2025-05-05 (Dawn Health, $13M), and 9 of 12 entries fall between 2023-07-18 and 2025-05-05. Stage/disclosure is dominated by missing specifics: 7 of 12 are “Series Unknown,” and 2 of 12 are explicitly “undisclosed,” leaving only 2 rows with stated series types (Orbis Medicines as Series A; others listed with blank series).
Most recent rounds
12 shownRelated listings
Frequently asked
What are the largest disclosed rounds in Copenhagen health care here, and how distinct are they from the rest?
Orbis Medicines’ $93M (2025-01-06, Series A) is the only disclosed round above $50M and it dwarfs the rest of the disclosed amounts; the next-largest disclosed entries are Dawn Health at $13M (2025-05-05) and CathVision at $9M (2023-07-18).
Do the rounds cluster in a narrow recent time window, or are they spread evenly across years?
They cluster toward the most recent period: 9 of 12 rows have round dates between 2023-07-18 (CathVision) and 2025-05-05 (Dawn Health). The oldest two in the list are Practio ($8M on 2020-08-11) and Sumondo ($200K on 2020-11-19).
How much of the list lacks disclosed or specified funding details (Series Unknown vs undisclosed amounts)?
Disclosed amounts are missing frequently and stage is often unspecified: 7 of 12 rows are labeled “Series Unknown,” and 2 of 12 show the amount as “undisclosed” (TetraKit Technologies on 2025-02-17 and Miiskin on 2025-01-23). Only Orbis Medicines (Series A, $93M on 2025-01-06) has a stated series type in the data.
Are there notable lows (including the smallest disclosed amount), and where do they sit relative to the larger rounds?
The smallest disclosed amount is Brain+ at $10K (2023-09-20). Even within the broader low-to-mid range, the disclosed figures like $290K (CS MEDICA, 2024-05-28) and $730K (Cessatech, 2024-08-12) are still far below the $13M and $93M points held by Dawn Health (2025-05-05) and Orbis Medicines (2025-01-06).
Which entries concentrate in the same geography label, and does the page suggest a broader dispersion beyond Copenhagen?
Every row is labeled Copenhagen, Hovedstaden, Denmark, including Dawn Health (2025-05-05) and Practio (2020-08-11). There is no city variation shown, so dispersion beyond Copenhagen is not indicated by the listing.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.